Panagora Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Panagora Asset Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,327	Closed	-$160K	–	2737
2020 Q1	$160K	Sell	3,327 -221	-6%	-$10.3K	﹤0.01%	1528
2019 Q4	$167K	Buy	+3,548	New	+$157K	﹤0.01%	1667

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Panagora Asset Management's RARX Position: Q2 2020 in Review

Panagora Asset Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 3,327 shares — an estimated $160K sold.

Panagora Asset Management first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $167K in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Panagora Asset Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Panagora Asset Management sold 3,327 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $160K.
Panagora Asset Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Panagora Asset Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $167K in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Panagora Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.